A “game-changer” study claims bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive. Patients with advanced ...

In 2011, the FDA issued a safety warning for the antidiabetic drug pioglitazone (Actos). The warning states that use for longer than 1 year might be associated with excess risk for bladder cancer ...

there are no early screening tests available for bladder cancer. Therefore, most people are diagnosed after reporting symptoms, most commonly, blood in the urine. According to Dr. Girish Kulkarni ...

Bladder cancer affects over 52,000 men and women in the United States on an annual basis, and more than 12,000 people die each year from this disease. It is the fourth most common cancer in men in ...

Bladder cancer is one of the most common cancers, particularly affecting older adults. While it can occur at any age, awareness of its risk factors, symptoms, and treatment options is crucial for ...

Because the warning signs of bladder cancer are often mistaken for other health conditions like urinary tract and kidney infections, early detection may not be as clear-cut as other diseases. What are ...